Note to Readers - Newsletter to be sent October 6
Dear Readers,
Sunday’s newsletter will be delayed by a day; look for the next edition on Monday, October 6.
Thank you for your support! In the meantime, check out updated and expanded adverse event summaries on our website, with the 20 most commonly reported adverse reactions reported to the FDA for thousands of medications! Browse a list of available reports using the alpha-list or find a specific drug by using the form at the top of each page of the Ask a Patient website. For example, here is a link to the Ozempic report:
Charts and graphs with adverse reactions, outcomes, patient ages and sex, number of reports by year, and more for OZEMPIC (SEMAGLUTIDE) as reported in 40,933 cases to the FDA through June 2025 in the FAERS and MedWatch database.
Did you miss the last newsletter? Check it out here:
Nationwide Recalls for Cyclobenzaprine, Multiple Generics; Warnings for Briviact, Lupron Depot, Riluzole, Tepezza, Tiglutek; Pharma Ad Crackdown, More
Drug Recall: Cyclobenzaprine Hydrochloride